BOSTON, Sept. 17, 2026 (GLOBE NEWSWIRE) -- AVAVA, Inc., a medical aesthetics company pioneering next-generation energy-based technologies, today announced a $45 million financing led by Catalio Capital Management, LP, AVAVA’s first institutional investor and a longstanding partner in the company’s growth.

波士顿，2026年9月17日（环球电讯社）——医疗美容公司AVAVA, Inc.作为下一代能量源技术的先驱，今日宣布完成由Catalio Capital Management, LP领投的4500万美元融资。Catalio Capital是AVAVA的首家机构投资者，也是公司长期以来的成长合作伙伴。

The financing consists of $30 million in equity financing and a $15 million debt facility, providing additional capital to support AVAVA’s continued commercial expansion, innovation pipeline and global growth..

本次融资包括3000万美元的股权融资和1500万美元的债务融资额度，旨在为AVAVA的持续商业扩张、创新管线推进及全球增长提供额外资金支持。

The transaction builds on Catalio’s longstanding partnership with AVAVA and includes participation from new and existing investors. Catalio is leading both the equity and debt financing, reflecting its continued conviction in AVAVA’s technology, leadership and long-term growth opportunity.

本次交易建立在 Catalio 与 AVAVA 长期合作伙伴关系的基础之上，并有新老投资者参与。Catalio 同时主导了股权和债务融资，这反映了其对 AVAVA 的技术、领导团队以及长期增长机会的持续信心。

“AVAVA is entering an exciting new phase of growth,” said Clint Carnell, Chief Executive Officer of AVAVA, Inc. “Catalio believed in our technology and our vision early, and their continued support speaks to the opportunity ahead of us. This financing gives us additional resources to scale our business, advance our innovation pipeline and bring AVAVA technology to more providers and patients around the world.”.

“AVAVA 正步入一个令人振奋的全新发展阶段，”AVAVA 公司首席执行官克林特·卡内尔表示。“Catalio 早期便对我们的技术和愿景充满信心，他们持续的支持彰显了我们面前的广阔机遇。此次融资为我们提供了更多资源，以扩大业务规模、推进创新管线，并将 AVAVA 的技术带给全球更多的医疗服务提供者和患者。”

Catalio became AVAVA’s first institutional investor, backing the company’s groundbreaking technology and its potential to create a differentiated platform in medical aesthetics. Since its initial investment, Catalio has remained an important partner as AVAVA has advanced its technology, expanded its commercial organization and increased its presence in the market..

Catalio 成为 AVAVA 的首家机构投资者，支持该公司的突破性技术及其在医美领域打造差异化平台的潜力。自首次投资以来，随着 AVAVA 推进技术发展、扩大商业组织规模并提升市场影响力，Catalio 一直保持着重要的合作伙伴关系。

A key focus for AVAVA moving forward is the continued advancement of its proprietary Focal Point Technology®. Future iterations of the technology are currently in development and have begun testing, reflecting continued progress across AVAVA’s innovation pipeline and the company’s commitment to advancing what is possible in energy-based aesthetics..

AVAVA 未来的一个关键重点是持续推进其专有的 Focal Point Technology®。该技术的未来迭代版本目前正在开发中并已开始测试，这体现了 AVAVA 创新产品线的持续进展，以及公司致力于推动能量源美容技术可能性的承诺。

“Some of the most important advances in medicine begin by challenging assumptions about what technology can do,” said R. Rox Anderson, M.D., co-founder and member of the Board of Directors of AVAVA, Inc. “That thinking has been at the heart of AVAVA from the beginning. Focal Point Technology® opens new possibilities for how we deliver energy to the skin, and we are only beginning to explore its potential.”.

“医学领域的一些最重要进展，始于对技术能力固有假设的挑战。”AVAVA公司联合创始人兼董事会成员R. Rox Anderson博士表示。“这种思维方式自始至终都是AVAVA的核心理念。Focal Point Technology®为我们向皮肤输送能量开启了新的可能性，而我们对这一潜力的探索才刚刚起步。”

The financing comes at an important stage in AVAVA’s growth. The company recently launched its AVAVA 2.0 software upgrade, continues to advance its clinical and regulatory programs, and is expanding its commercial and international footprint.

此次融资正值AVAVA发展的关键阶段。公司近期推出了AVAVA 2.0软件升级，持续推进其临床和监管项目，并不断扩大其商业布局和国际影响力。

“From the beginning, AVAVA was built around the belief that there was a fundamentally different way to deliver energy in aesthetics,” added Carnell. “We’ve made tremendous progress bringing that vision to market. This next phase is about building on that foundation, continuing to innovate, scaling thoughtfully and taking AVAVA to the world.”.

“从一开始，AVAVA 就基于一种信念构建而成，即在美学领域输送能量存在一种根本不同的方式，”卡内尔补充道。“我们在将这一愿景推向市场方面取得了巨大进展。下一阶段的重点是在此基础上继续创新，审慎地扩大规模，并将 AVAVA 推向全球。”

AVAVA was advised by UBS Investment Bank and Oak Hill Securities in connection with the financing.

在融资方面，AVAVA 获得了瑞银投资银行和橡树山证券的顾问服务。

About AVAVA, Inc.

关于 AVAVA 公司

AVAVA, Inc. is redefining energy-based aesthetics through its patented Focal Point Technology®, a novel approach to delivering energy with precision while preserving surrounding tissue. AVAVA’s technology is designed to enable highly customizable treatments across a broad range of skin types and treatment areas..

AVAVA公司正通过其专利的Focal Point Technology®（焦点技术）重新定义基于能量的美学治疗。该技术是一种创新方法，能够精准输送能量，同时保护周围组织。AVAVA的技术旨在为广泛的皮肤类型和治疗区域提供高度定制化的治疗方案。

With continued investment in clinical research, technology innovation and commercial expansion, AVAVA is advancing a new approach to energy-based aesthetics built around precision, versatility and inclusivity.

凭借在临床研究、技术创新和商业扩张方面的持续投入，AVAVA 正在推进一种以精准性、多功能性和包容性为核心的能量源医美新范式。

All Skin. All Body. All Year.

全身肌肤，全年呵护。

About Catalio Capital Management, LP

关于 Catalio Capital Management, LP

Catalio Capital Management, LP, is a New York-based investment firm focused on the full lifecycle of innovative healthcare investing across private, public and credit markets. Catalio has exclusive partnerships with world-renowned serial scientist-entrepreneurs from around the globe who each have extensive academic and scientific achievements and who have also started multiple well-established companies based on their research.

Catalio Capital Management, LP 是一家总部位于纽约的投资公司，专注于在私募、公开和信贷市场中对创新医疗健康领域进行全生命周期投资。Catalio 与来自全球的知名连续科学家创业者建立了独家合作伙伴关系，这些合作伙伴均拥有深厚的学术和科学成就，并基于其研究成果创办了多家成熟的企业。

Catalio has offices in New York, London, and Washington, D.C. Learn more about Catalio Capital Management by visiting .

Catalio 在纽约、伦敦和华盛顿特区设有办事处。访问以了解更多关于 Catalio Capital Management 的信息。

www.cataliocapital.com

www.cataliocapital.com

.

。

Media Contact

媒体联系人

Stacy Mackler

斯泰西·麦克勒

AVAVA, Inc.

AVAVA 公司

smackler@avavaskin.com

smackler@avavaskin.com

(917) 509-0890

(917) 509-0890